Abingworth LLP
- SEC CIK
- 0001397144
- Latest filing
- Feb 10, 2023
Holdings in Q2 2021
Holdings as of Jun 30, 2021, filed Aug 16, 2021. Long positions only; changes compare share counts with Q1 2021.
- Positions
- 19
- +2 vs. Q1 2021
- Portfolio value
- $323.5M
- +$34.0M (+11.7%) vs. Q1 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| OCGNOcugen, Inc. | Common | 7,111 | $57.0K | <0.1% | 00.0% | Unchanged | History |
| OBSVObsEva SA | COM | 87,999 | $266.0K | 0.1% | 00.0% | Unchanged | History |
| CBAYCymaBay Therapeutics, Inc. | COM | 131,036 | $571.0K | 0.2% | 00.0% | Unchanged | History |
| XFORX4 Pharmaceuticals, Inc | COM | 229,885 | $1.49M | 0.5% | 00.0% | Unchanged | History |
| MTEMMolecular Templates, Inc. | COM | 200,000 | $1.56M | 0.5% | 00.0% | Unchanged | History |
| SYRESpyre Therapeutics, Inc. | COM | 240,500 | $1.67M | 0.5% | 00.0% | Unchanged | History |
| PRTKParatek Pharmaceuticals, Inc. | COM | 1,041,131 | $7.09M | 2.2% | 00.0% | Unchanged | History |
| NCNANuCana plc | SPONSORED ADR | 3,333,333 | $9.20M | 2.8% | 00.0% | Unchanged | History |
| XCURExicure, Inc. | COM | 6,977,000 | $10.4M | 3.2% | 00.0% | Unchanged | History |
| SLNOSoleno Therapeutics Inc | COM NEW | 10,302,602 | $11.6M | 3.6% | 00.0% | Unchanged | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 2,457,499 | $16.0M | 4.9% | 00.0% | Unchanged | History |
| ACETAdicet Bio, Inc. | COM | 1,615,385 | $16.6M | 5.1% | 00.0% | Unchanged | History |
| SRRASierra Oncology, Inc. | COM | 871,125 | $16.8M | 5.2% | 00.0% | Unchanged | History |
| OKUROnKure Therapeutics, Inc. | COM | 1,962,221 | $18.2M | 5.6% | +1,962,221 | New | History |
| SIENProject Sage Oldco, Inc. | COM | 2,390,843 | $19.0M | 5.9% | 00.0% | Unchanged | History |
| Spruce BioE5209E109 | Common | 1,792,518 | $20.1M | 6.2% | 00.0% | Unchanged | – |
| VERAVera Therapeutics, Inc. | CL A | 2,960,231 | $38.5M | 11.9% | +2,960,231 | New | History |
| PHATPhathom Pharmaceuticals, Inc. | COM | 1,203,135 | $40.7M | 12.6% | 00.0% | Unchanged | History |
| PCVXVaxcyte, Inc. | COM | 4,168,718 | $93.6M | 28.9% | 00.0% | Unchanged | History |